Remove Access Remove Conditions Remove Pharmaceutical Remove Sleep
article thumbnail

Exploring Medical Marijuana for Chronic Conditions

MMJ Recs

We will be exploring cannabis therapy for chronic conditions. There’s also neuropathic pain, which results from nerve damage, leading to conditions such as shingles or nerve compression. This is where exploring cannabis therapy for chronic conditions enters the picture as a promising alternative.

article thumbnail

Could CBN really help you sleep? Consumer study data suggest yes.

The Cannigma

CBN has made headlines and claimed shelf space as the next best cannabinoid for sleep. MoreBetter, creators of the Releaf App, is using this real world data to push back against the claim that there’s no evidence that CBN can help people sleep. It also, allegedly, helps with sleep (more on that below). Back to our study.

Sleep 133
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Why You Should Choose Lazarus Naturals CBD for Sleep

Cannabis Law Report

When it comes to natural ways to help you sleep, your options may be limited. As much as you feel like you’re going to lose your mind trying to get a good night’s sleep, let us tell you, there’s a solution to your problem, and you are not alone. CBD for Sleep and the Science Behind it. It contains less than 0.3%

Sleep 52
article thumbnail

Finding Hope: MMJ’s Impact on Maryland Communities

MMJ Recs

By legalizing MMJ, the state has facilitated access to a natural and potentially life-changing treatment option for patients suffering from various medical conditions. It has improved the quality of life for those dealing with chronic pain, nausea, seizures, and other medical conditions. Image by Pfüderi from Pixabay.

article thumbnail

Global Psychiatry Deals Report 2014-2021: Access to Headline, Upfront, Milestone and Royalty Data – ResearchAndMarkets.com

Cannabis Law Report

Global Psychiatry Partnering 2014 to 2021 provides the full collection of Psychiatry disease deals signed between the world’s pharmaceutical and biotechnology companies since 2014. Access to headline, upfront, milestone and royalty data. Access to hundreds of Psychiatry deal contract documents. Report Scope.

Access 52
article thumbnail

Canopy Growth Divests Pharmaceutical C3 Cannabinoid Compound Company

Cannabis Law Report

Canopy Growth Corporation (“Canopy Growth” or the “Company”) (TSX: WEED) (NASDAQ: CGC ) has entered into an agreement to divest its subsidiary business, C³ Cannabinoid Compound Company GmbH (“C3”), to Dermapharm Holding SE (“Dermapharm”) (WKN: A2GS5D, ISIN: DE000A2GS5D8), a European pharmaceutical company headquartered in Grünwald, Germany.

article thumbnail

Unlocking the Potential of CBD: Exploring The Benefits of CBD in Medical Marijuana

MMJ Recs

CBD, one of the many cannabinoids found in the cannabis plant, has been garnering attention for its promising effects on various health conditions. From its anti-inflammatory properties to its ability to alleviate pain, CBD shows promise in addressing various health conditions.

CBD 52